Holmøy T - Search Results

1

Approach to bone protection in multiple sclerosis.

McKenna MJ, Holmøy T. McKenna MJ, et al. Among authors: holmoy t. Eur J Neurol. 2015 Apr;22(4):601-2. doi: 10.1111/ene.12504. Epub 2014 Jul 2. Eur J Neurol. 2015. PMID: 24986035 No abstract available.

2

Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome.

Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmøy T. Moen SM, et al. Among authors: holmoy t. Neurology. 2011 Jul 12;77(2):151-7. doi: 10.1212/WNL.0b013e3182242d34. Neurology. 2011. PMID: 21747073

3

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T. Røsjø E, et al. Among authors: holmoy t. J Neurol. 2015 Dec;262(12):2713-21. doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1. J Neurol. 2015. PMID: 26429571 Clinical Trial.

4

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø. Wergeland S, et al. Among authors: holmoy t. Eur J Neurol. 2016 Jun;23(6):1064-70. doi: 10.1111/ene.12986. Epub 2016 Mar 21. Eur J Neurol. 2016. PMID: 26998820 Clinical Trial.

5

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT. Holmøy T, et al. BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0. BMC Neurol. 2017. PMID: 28376767 Free PMC article. Clinical Trial.

6

T cells in amyotrophic lateral sclerosis.

Holmøy T. Holmøy T. Eur J Neurol. 2008 Apr;15(4):360-6. doi: 10.1111/j.1468-1331.2008.02065.x. Epub 2008 Feb 11. Eur J Neurol. 2008. PMID: 18266871 Review.

7

Alaska, multiple sclerosis, and the vitamin D hypothesis.

Holmøy T, Kampman MT. Holmøy T, et al. J Neurol. 2010 Feb;257(2):305-6. doi: 10.1007/s00415-009-5360-7. Epub 2009 Oct 28. J Neurol. 2010. PMID: 19862468 No abstract available.

8

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J; SOLAR Study Group. Grimaldi L, et al. Among authors: holmoy t. Neurology. 2012 Mar 13;78(11):841. doi: 10.1212/01.wnl.0000413180.13413.ce. Neurology. 2012. PMID: 22411961 No abstract available.

9

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM. Løken-Amsrud KI, et al. Among authors: holmoy t. Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13. Neurology. 2012. PMID: 22700809

10

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O. Kampman MT, et al. Among authors: holmoy t. J Neurol. 2013 Jun;260(6):1481-8. doi: 10.1007/s00415-012-6814-x. Epub 2013 Jan 6. J Neurol. 2013. PMID: 23292231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page